Iron Dextran Injection
Product Images NDC 51662-1441

This is a boxed warning for INFeD, an iron dextran injection. There is a risk for anaphylactic-type reactions, including fatalities, after the parenteral administration of the injection. Healthcare providers should have resuscitation equipment and personnel trained in the detection and treatment of such reactions readily available during INFeD administration. It is recommended to administer a test INFeD dose prior to the first therapeutic dose and observe for any signs or symptoms of anaphylactic-type reactions during all INFeD injections. INFeD should only be used in patients who have had clinical and laboratory investigations establish an iron deficient state not treatable with oral iron therapy. Patients with a history of drug allergy or multiple drug allergies may be at an increased risk of anaphylactic-type reactions to INFeD.*

This is a formula for calculating the amount of iron in milligrams in a person's blood. It involves multiplying the person's blood volume in milliliters, their hemoglobin concentration in grams per milliliter, and the amount of iron in milligrams per gram of hemoglobin. The formula includes variables for body weight in pounds, blood volume in milliliters, and hemoglobin concentration in grams per milliliter.*

The text "patient's weight in pounds" indicates that the document is likely related to healthcare or medical records, specifically a patient's weight measurement. The accompanying number "2" doesn't provide enough context to determine its significance.*

INFeD is a medication that comes in a dose of 100 mg, which is equivalent to 2 mL. The rest of the text is not legible.*

This text appears to be a label on a package of Iron Dextran injection solution. It includes information such as the product's National Drug Code (NDC), lot number (18W06A), and the manufacturer's contact information. It also refers the reader to consult the manufacturer's package insert for further details.*

INFeD is an injectable medication that contains iron dextran and provides 100 mg of elemental iron per 2 ml (50 mg/ml) of solution. This medication is prescribed to treat iron deficiency anemia when oral iron supplements are ineffective or cannot be used. The National Drug Code (NDC) for this medication is 0023-6082-01.*

This is a sterile single-dose vial for intramuscular or intravenous use. The label indicates that there may be a package insert for more instructions. This product was distributed by Allergan UK from their office in Irvine, CA. It was manufactured by Patheon S located in Ferentino, Italy in 2017.*